Diabetes Drug Shows Benefit in Parkinson's Disease : vimarsana.com

Phase II study of GLP-1 drug lixisenatide meets primary endpoint

Related Keywords

France , David Standaert , Olivier Rascol , Judy George , Movement Disorder Society , University Of Toulouse , University Of Alabama At Birmingham , Movement Disorder Society Unified Parkinson , Disease Rating Scale , New England Journalof , Medpage Today , England Journal , Englj Med ,